Heparanase promotes glioma progression via enhancing CD24 expression
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Heparanase promotes glioma progression via enhancing CD24 expression
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-04-30
DOI
10.1002/ijc.32375
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours
- (2018) Keith Dredge et al. BRITISH JOURNAL OF CANCER
- Involvement of CD24 in Multiple Cancer Related Pathways Makes It an Interesting New Target for Cancer Therapy
- (2018) Shirin Eyvazi et al. CURRENT CANCER DRUG TARGETS
- Phase I study of the heparanase inhibitor Roneparstat: an innovative approach for multiple myeloma therapy
- (2018) Monica Galli et al. HAEMATOLOGICA
- Involvement of Heparanase in the Pathogenesis of Mesothelioma: Basic Aspects and Clinical Applications
- (2018) Uri Barash et al. JNCI-Journal of the National Cancer Institute
- Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression
- (2018) Israel Vlodavsky et al. TRENDS IN BIOCHEMICAL SCIENCES
- Phase I study of the heparanase inhibitor Roneparstat: an innovative approach for multiple myeloma therapy
- (2018) Monica Galli et al. HAEMATOLOGICA
- Involvement of Heparanase in the Pathogenesis of Mesothelioma: Basic Aspects and Clinical Applications
- (2018) Uri Barash et al. JNCI-Journal of the National Cancer Institute
- Pro-Angiogenic Effects of Latent Heparanase and Thrombin Receptor-Mediated Pathways—Do They Share a Common Ground in Melanoma Cells?
- (2018) Sebastian Hoß et al. THROMBOSIS AND HAEMOSTASIS
- Inhibition of Heparanase in Pediatric Brain Tumor Cells Attenuates their Proliferation, Invasive Capacity, and In Vivo Tumor Growth
- (2017) Argyris Spyrou et al. MOLECULAR CANCER THERAPEUTICS
- The CD24 surface antigen in neural development and disease
- (2017) Daniel T. Gilliam et al. NEUROBIOLOGY OF DISEASE
- Prognostic significance of heparanase expression in primary and metastatic breast carcinoma
- (2017) Olga Vornicova et al. Oncotarget
- Heparanase: From basic research to therapeutic applications in cancer and inflammation
- (2016) Israel Vlodavsky et al. DRUG RESISTANCE UPDATES
- Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases
- (2016) Silvia Rivara et al. Future Medicinal Chemistry
- Heparanase Promotes Glioma Progression and Is Inversely Correlated with Patient Survival
- (2016) Soumi Kundu et al. MOLECULAR CANCER RESEARCH
- Heparanase augments insulin receptor signaling in breast carcinoma
- (2016) Rachel Goldberg et al. Oncotarget
- Heparanase Enhances Tumor Growth and Chemoresistance by Promoting Autophagy
- (2015) Anna Shteingauz et al. CANCER RESEARCH
- Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma
- (2015) Vishnu C. Ramani et al. Oncotarget
- Heparanase Cooperates with Ras to Drive Breast and Skin Tumorigenesis
- (2014) I. Boyango et al. CANCER RESEARCH
- Processing of heparanase is mediated by syndecan-1 cytoplasmic domain and involves syntenin and α-actinin
- (2014) Anna Shteingauz et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Heparanase enhances myeloma progression via CXCL10 downregulation
- (2014) U Barash et al. LEUKEMIA
- Soluble Heparan Sulfate Fragments Generated by Heparanase Trigger the Release of Pro-Inflammatory Cytokines through TLR-4
- (2014) Katharine J. Goodall et al. PLoS One
- The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics
- (2014) Edward Hammond et al. Frontiers in Oncology
- Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models
- (2013) G. Cassinelli et al. BIOCHEMICAL PHARMACOLOGY
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation
- (2013) C.R. Parish et al. MATRIX BIOLOGY
- Glioma-derived macrophage migration inhibitory factor (MIF) promotes mast cell recruitment in a STAT5-dependent manner
- (2013) Jelena Põlajeva et al. Molecular Oncology
- Macrophage Activation by Heparanase Is Mediated by TLR-2 and TLR-4 and Associates With Plaque Progression
- (2012) Miry Blich et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- CD24 controls Src/STAT3 activity in human tumors
- (2012) Niko P. Bretz et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Heparanase Enhances the Insulin Receptor Signaling Pathway to Activate Extracellular Signal-regulated Kinase in Multiple Myeloma
- (2012) Anurag Purushothaman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clinical Significance of Heparanase Splice Variant (T5) in Renal Cell Carcinoma: Evaluation by a Novel T5-Specific Monoclonal Antibody
- (2012) Uri Barash et al. PLoS One
- CD24 Offers a Therapeutic Target for Control of Bladder Cancer Metastasis Based on a Requirement for Lung Colonization
- (2011) J. B. Overdevest et al. CANCER RESEARCH
- Heparanase Induces Signal Transducer and Activator of Transcription (STAT) Protein Phosphorylation
- (2011) Victoria Cohen-Kaplan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CD24: from A to Z
- (2010) Xianfeng Fang et al. Cellular & Molecular Immunology
- Post-transcriptional regulation of heparanase gene expression by a 3′ AU-rich element
- (2010) Gil Arvatz et al. FASEB JOURNAL
- Proteoglycans in cancer biology, tumour microenvironment and angiogenesis
- (2010) Renato V. Iozzo et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis
- (2010) Glen Kristiansen et al. LABORATORY INVESTIGATION
- Structure-Function Approach Identifies a COOH-Terminal Domain That Mediates Heparanase Signaling
- (2009) L. Fux et al. CANCER RESEARCH
- A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics
- (2009) Uri Barash et al. FASEB JOURNAL
- Heparanase expression of glioma in human and animal models
- (2009) Xin Hong et al. JOURNAL OF NEUROSURGERY
- Heparanase: busy at the cell surface
- (2009) Liat Fux et al. TRENDS IN BIOCHEMICAL SCIENCES
- Targeting CD24 for Treatment of Colorectal and Pancreatic Cancer by Monoclonal Antibodies or Small Interfering RNA
- (2008) E. Sagiv et al. CANCER RESEARCH
- Heparanase Augments Epidermal Growth Factor Receptor Phosphorylation: Correlation with Head and Neck Tumor Progression
- (2008) V. Cohen-Kaplan et al. CANCER RESEARCH
- Heparanase induces VEGF C and facilitates tumor lymphangiogenesis
- (2008) Victoria Cohen-Kaplan et al. INTERNATIONAL JOURNAL OF CANCER
- Heparanase Stimulation of Protease Expression Implicates It as a Master Regulator of the Aggressive Tumor Phenotype in Myeloma
- (2008) Anurag Purushothaman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started